SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-18-075228
Filing Date
2018-03-08
Accepted
2018-03-08 16:28:03
Documents
1
Period of Report
2017-12-19
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Document Format Files

Seq Description Document Type Size
1 8-K/A d549795d8ka.htm 8-K/A 14052
  Complete submission text file 0001193125-18-075228.txt   15441
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-31326 | Film No.: 18676822
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services